Torl Biotherapeutics, Llc

This early-stage study is testing a new drug called TORL-5-700 for people with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to other treatments. Researchers will give the drug alone and in combination with other medicines to about 155 participants to see if …